JCO Oncology Advances
Displaying 1 - 2 of 2
Restar, A. J., Lucas, R., NFN, S., Alpert, A. B., Phipps, A., Wang, G., Operario, D., Radix, A., van der Merwe, L. A., Lindström, S., Everhart, A., Gamarel, K. E., & Streed, C. G. (2025). Underinvested, Under-Referred, and Underserved: Applying a Gender Equity Continuum Framework in Cancer Control Continuum Programs and Policies to Expand to Transgender and Nonbinary Populations. JCO Oncology Advances, 2. https://doi.org/10.1200/oa.24.00023
Publication Date
Columbia Affiliation
View
Manji, G. A., Stanton, L. J., Hirbe, A. C., Ge, L., Sta Ana, S., Titus, S., Labadie, B. W., May, M. S., Lyu, Y., Chrisinger, J. S. A., Sender, N., Monga, V., Milhem, M., Chugh, R., Sims, P., Tan, A. C., Lee, S., Van Tine, B. A., & Schwartz, G. K. (2025). Phase II Study of Pexidartinib Plus Sirolimus in Unresectable Malignant Peripheral Nerve Sheath Tumors Identifies M2 Macrophage Activation. JCO Oncology Advances, 2. https://doi.org/10.1200/oa-24-00083
Publication Date
Columbia Affiliation
View